Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,052
archived clinical trials in
Nephrology

Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated:  12/12/2012
Ohio State University
mi
from
Columbus, OH
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated: 12/12/2012
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated:  12/12/2012
Doernbecher Children's Hospital
mi
from
Portland, OR
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated: 12/12/2012
Doernbecher Children's Hospital
mi
from
Portland, OR
Click here to add this to my saved trials
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated:  12/12/2012
Medical University of South Carolina
mi
from
Charleston, SC
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated: 12/12/2012
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated:  12/12/2012
Texas Tech University
mi
from
El Paso, TX
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated: 12/12/2012
Texas Tech University
mi
from
El Paso, TX
Click here to add this to my saved trials
Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
A Multicenter, Double-Blind, Randomized, Phase 3 Study to Compare the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
Status: Enrolling
Updated:  1/22/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
A Multicenter, Double-Blind, Randomized, Phase 3 Study to Compare the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
Status: Enrolling
Updated: 1/22/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
A Multicenter, Double-Blind, Randomized, Phase 3 Study to Compare the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
Status: Enrolling
Updated:  1/22/2013
Clinical Research Facility
mi
from
Decatur, GA
Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
A Multicenter, Double-Blind, Randomized, Phase 3 Study to Compare the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
Status: Enrolling
Updated: 1/22/2013
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
A Multicenter, Double-Blind, Randomized, Phase 3 Study to Compare the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
Status: Enrolling
Updated:  1/22/2013
Clinical Research Facility
mi
from
Jackson, MS
Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
A Multicenter, Double-Blind, Randomized, Phase 3 Study to Compare the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
Status: Enrolling
Updated: 1/22/2013
Clinical Research Facility
mi
from
Jackson, MS
Click here to add this to my saved trials
Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
A Multicenter, Double-Blind, Randomized, Phase 3 Study to Compare the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
Status: Enrolling
Updated:  1/22/2013
Clinical Research Facility
mi
from
Cleveland, OH
Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
A Multicenter, Double-Blind, Randomized, Phase 3 Study to Compare the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
Status: Enrolling
Updated: 1/22/2013
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
A Multicenter, Double-Blind, Randomized, Phase 3 Study to Compare the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
Status: Enrolling
Updated:  1/22/2013
Clinical Research Facility
mi
from
Dallas, TX
Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
A Multicenter, Double-Blind, Randomized, Phase 3 Study to Compare the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
Status: Enrolling
Updated: 1/22/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
A Multicenter, Double-Blind, Randomized, Phase 3 Study to Compare the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
Status: Enrolling
Updated:  1/22/2013
Clinical Research Facility
mi
from
Norfolk, VA
Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
A Multicenter, Double-Blind, Randomized, Phase 3 Study to Compare the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
Status: Enrolling
Updated: 1/22/2013
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Nephrogenic Systemic Fibrosis (NSF): Analysis of Tissue Gadolinium Levels
Nephrogenic Systemic Fibrosis and Gadolinium—A Medical Record Review With Analysis of Existing Skin and Other Tissue Specimens to Assess Potential Causative or Associated Factors
Status: Enrolling
Updated:  2/14/2013
Northwestern University, Feinberg School of Medicine, Department of Dermatology
mi
from
Chicago, IL
Nephrogenic Systemic Fibrosis (NSF): Analysis of Tissue Gadolinium Levels
Nephrogenic Systemic Fibrosis and Gadolinium—A Medical Record Review With Analysis of Existing Skin and Other Tissue Specimens to Assess Potential Causative or Associated Factors
Status: Enrolling
Updated: 2/14/2013
Northwestern University, Feinberg School of Medicine, Department of Dermatology
mi
from
Chicago, IL
Click here to add this to my saved trials
Management of Ureteral Calculi Using Ultrasound Guidance: A Radiation Free Approach
Management of Ureteral Calculi Using Ultrasound Guidance: A Radiation Free Approach
Status: Enrolling
Updated:  2/14/2013
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Management of Ureteral Calculi Using Ultrasound Guidance: A Radiation Free Approach
Management of Ureteral Calculi Using Ultrasound Guidance: A Radiation Free Approach
Status: Enrolling
Updated: 2/14/2013
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Cysteamine Eye Drops to Treat Corneal Crystals in Cystinosis
Trial of Topical Cysteamine in the Treatment of Corneal Cystine Crystal Accumulation in Cystinosis
Status: Enrolling
Updated:  5/1/2013
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Cysteamine Eye Drops to Treat Corneal Crystals in Cystinosis
Trial of Topical Cysteamine in the Treatment of Corneal Cystine Crystal Accumulation in Cystinosis
Status: Enrolling
Updated: 5/1/2013
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)
"Safety and Efficacy of Acthar Gel on Albuminuria and Urinary Transforming Growth Factor Excretion in Type I or Type II Diabetics Requiring Medical Treatment of Hyperglycemia With Nephrotic Range Proteinuria: A Pilot Study"
Status: Enrolling
Updated:  5/30/2013
Southeast Renal Research Institute
mi
from
Chattanooga, TN
Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)
"Safety and Efficacy of Acthar Gel on Albuminuria and Urinary Transforming Growth Factor Excretion in Type I or Type II Diabetics Requiring Medical Treatment of Hyperglycemia With Nephrotic Range Proteinuria: A Pilot Study"
Status: Enrolling
Updated: 5/30/2013
Southeast Renal Research Institute
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Feasibility and Impact of a Decision Rule for Imaging of Emergency Department Patients With Suspected Kidney Stone
Feasibility and Impact of a Decision Rule for Imaging of Emergency Department Patients With Suspected Kidney Stone
Status: Enrolling
Updated:  5/30/2013
Yale University
mi
from
New Haven, CT
Feasibility and Impact of a Decision Rule for Imaging of Emergency Department Patients With Suspected Kidney Stone
Feasibility and Impact of a Decision Rule for Imaging of Emergency Department Patients With Suspected Kidney Stone
Status: Enrolling
Updated: 5/30/2013
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Electrohydraulic Versus Laser Lithotripsy for Treatment of Difficult to Remove Biliary Stones
Electrohydraulic Versus Laser Lithotripsy for Treatment of Difficult to Remove Biliary Stones
Status: Enrolling
Updated:  7/29/2013
Cleveland Clinic
mi
from
Cleveland, OH
Electrohydraulic Versus Laser Lithotripsy for Treatment of Difficult to Remove Biliary Stones
Electrohydraulic Versus Laser Lithotripsy for Treatment of Difficult to Remove Biliary Stones
Status: Enrolling
Updated: 7/29/2013
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Fort Smith, AR
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Fort Smith, AR
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Santa Clara, CA
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Aurora, CO
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Washington,
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Park Ridge, IL
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Park Ridge, IL
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Indianapolis, IN
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Metairie, LA
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Metairie, LA
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Boston, MA
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Omaha, NE
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Newark, NJ
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
New York, NY
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Cleveland, OH
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
Clinical Research Facility
mi
from
Philadelphia, PA
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients
Study of Triple Blockade of the Renin Angiotensin Aldosterone System (RAAS) in Diabetic (Type 1&2) Proteinuric Patients With (ACE-, ARB, DRI)
Status: Enrolling
Updated:  10/24/2013
John H Stroger Hospital of Cook County
mi
from
Chicago, IL
Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients
Study of Triple Blockade of the Renin Angiotensin Aldosterone System (RAAS) in Diabetic (Type 1&2) Proteinuric Patients With (ACE-, ARB, DRI)
Status: Enrolling
Updated: 10/24/2013
John H Stroger Hospital of Cook County
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated:  12/11/2013
Clinical Research Facility
mi
from
Phoenix, AZ
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated: 12/11/2013
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated:  12/11/2013
Clinical Research Facility
mi
from
Danbury, CT
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated: 12/11/2013
Clinical Research Facility
mi
from
Danbury, CT
Click here to add this to my saved trials
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated:  12/11/2013
Clinical Research Facility
mi
from
Kansas City, KA
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated: 12/11/2013
Clinical Research Facility
mi
from
Kansas City, KA
Click here to add this to my saved trials
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated:  12/11/2013
Clinical Research Facility
mi
from
Manhasset, NY
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated: 12/11/2013
Clinical Research Facility
mi
from
Manhasset, NY
Click here to add this to my saved trials
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated:  12/11/2013
Clinical Research Facility
mi
from
New York, NY
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated: 12/11/2013
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated:  12/11/2013
Clinical Research Facility
mi
from
Duncansville, PA
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated: 12/11/2013
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated:  12/11/2013
Clinical Research Facility
mi
from
Amarillo, TX
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated: 12/11/2013
Clinical Research Facility
mi
from
Amarillo, TX
Click here to add this to my saved trials
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated:  12/11/2013
Clinical Research Facility
mi
from
Dallas, TX
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated: 12/11/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Effect of Sodium Thiosulfate on Urine Chemistries of Hypercalciuric Stone Formers
Pilot Study : Effect of Sodium Thiosulfate on Urine Chemistries of Hypercalciuric Stone Formers
Status: Enrolling
Updated:  12/23/2013
Va New York Harbor Healthcare System
mi
from
New York, NY
Effect of Sodium Thiosulfate on Urine Chemistries of Hypercalciuric Stone Formers
Pilot Study : Effect of Sodium Thiosulfate on Urine Chemistries of Hypercalciuric Stone Formers
Status: Enrolling
Updated: 12/23/2013
Va New York Harbor Healthcare System
mi
from
New York, NY
Click here to add this to my saved trials
MRI Hydronephrosis Study
Comparison of Rapid Protocol Noncontrast MRI vs. Ultrasound in the Evaluation of Pediatric Hydronephrosis
Status: Enrolling
Updated:  1/21/2014
University of Michigan
mi
from
Ann Arbor, MI
MRI Hydronephrosis Study
Comparison of Rapid Protocol Noncontrast MRI vs. Ultrasound in the Evaluation of Pediatric Hydronephrosis
Status: Enrolling
Updated: 1/21/2014
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Functional MRI in Lupus Nephritis
Noninvasive Assessment Of Renal Activity And Damage Using Renal Functional MRI In Normal Healthy Volunteers And Subjects With Lupus Nephritis
Status: Enrolling
Updated:  1/31/2014
Clinical Research Facility
mi
from
Los Angeles, CA
Functional MRI in Lupus Nephritis
Noninvasive Assessment Of Renal Activity And Damage Using Renal Functional MRI In Normal Healthy Volunteers And Subjects With Lupus Nephritis
Status: Enrolling
Updated: 1/31/2014
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Functional MRI in Lupus Nephritis
Noninvasive Assessment Of Renal Activity And Damage Using Renal Functional MRI In Normal Healthy Volunteers And Subjects With Lupus Nephritis
Status: Enrolling
Updated:  1/31/2014
Clinical Research Facility
mi
from
New York, NY
Functional MRI in Lupus Nephritis
Noninvasive Assessment Of Renal Activity And Damage Using Renal Functional MRI In Normal Healthy Volunteers And Subjects With Lupus Nephritis
Status: Enrolling
Updated: 1/31/2014
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Functional MRI in Lupus Nephritis
Noninvasive Assessment Of Renal Activity And Damage Using Renal Functional MRI In Normal Healthy Volunteers And Subjects With Lupus Nephritis
Status: Enrolling
Updated:  1/31/2014
Clinical Research Facility
mi
from
Columbus, OH
Functional MRI in Lupus Nephritis
Noninvasive Assessment Of Renal Activity And Damage Using Renal Functional MRI In Normal Healthy Volunteers And Subjects With Lupus Nephritis
Status: Enrolling
Updated: 1/31/2014
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Hydronephrosis ARFI Study
Evaluation of Ultrasound Acoustic Radiation Force Impulse (ARFI)Shear Wave Velocity Imaging (SVI)in the Characterization of Pediatric Hydronephrosis
Status: Enrolling
Updated:  6/4/2014
University of Michigan Health System
mi
from
Ann Arbor, MI
Hydronephrosis ARFI Study
Evaluation of Ultrasound Acoustic Radiation Force Impulse (ARFI)Shear Wave Velocity Imaging (SVI)in the Characterization of Pediatric Hydronephrosis
Status: Enrolling
Updated: 6/4/2014
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Community-Associated Uropathogen Antimicrobial Resistance Among Emergency Department Patients With Acute Pyelonephritis
Surveillance and Risk Factor Analysis of Community-Associated Uropathogen Antimicrobial Resistance Among Emergency Department Patients With Acute Pyelonephritis in the United States
Status: Enrolling
Updated:  10/15/2014
Olive View - UCLA Medical Center
mi
from
Sylmar, CA
Community-Associated Uropathogen Antimicrobial Resistance Among Emergency Department Patients With Acute Pyelonephritis
Surveillance and Risk Factor Analysis of Community-Associated Uropathogen Antimicrobial Resistance Among Emergency Department Patients With Acute Pyelonephritis in the United States
Status: Enrolling
Updated: 10/15/2014
Olive View - UCLA Medical Center
mi
from
Sylmar, CA
Click here to add this to my saved trials
Evaluating the Effect of ALLN-177 to Reduce Urinary Oxalate Excretion in Calcium Oxalate Kidney Stone Formers With Hyperoxaluria
A Phase 2 Multicenter, Open Label, Single Arm Study Evaluating the Effect of ALLN-177 to Reduce Urinary Oxalate Excretion in Recurrent Calcium Oxalate Kidney Stone Formers With Hyperoxaluria
Status: Enrolling
Updated:  11/12/2014
Indiana University Physicians Urology
mi
from
Indianapolis, IN
Evaluating the Effect of ALLN-177 to Reduce Urinary Oxalate Excretion in Calcium Oxalate Kidney Stone Formers With Hyperoxaluria
A Phase 2 Multicenter, Open Label, Single Arm Study Evaluating the Effect of ALLN-177 to Reduce Urinary Oxalate Excretion in Recurrent Calcium Oxalate Kidney Stone Formers With Hyperoxaluria
Status: Enrolling
Updated: 11/12/2014
Indiana University Physicians Urology
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Evaluating the Effect of ALLN-177 to Reduce Urinary Oxalate Excretion in Calcium Oxalate Kidney Stone Formers With Hyperoxaluria
A Phase 2 Multicenter, Open Label, Single Arm Study Evaluating the Effect of ALLN-177 to Reduce Urinary Oxalate Excretion in Recurrent Calcium Oxalate Kidney Stone Formers With Hyperoxaluria
Status: Enrolling
Updated:  11/12/2014
North Shore - Long Island Jewish Health System
mi
from
Lake Success, NY
Evaluating the Effect of ALLN-177 to Reduce Urinary Oxalate Excretion in Calcium Oxalate Kidney Stone Formers With Hyperoxaluria
A Phase 2 Multicenter, Open Label, Single Arm Study Evaluating the Effect of ALLN-177 to Reduce Urinary Oxalate Excretion in Recurrent Calcium Oxalate Kidney Stone Formers With Hyperoxaluria
Status: Enrolling
Updated: 11/12/2014
North Shore - Long Island Jewish Health System
mi
from
Lake Success, NY
Click here to add this to my saved trials
Evaluating the Effect of ALLN-177 to Reduce Urinary Oxalate Excretion in Calcium Oxalate Kidney Stone Formers With Hyperoxaluria
A Phase 2 Multicenter, Open Label, Single Arm Study Evaluating the Effect of ALLN-177 to Reduce Urinary Oxalate Excretion in Recurrent Calcium Oxalate Kidney Stone Formers With Hyperoxaluria
Status: Enrolling
Updated:  11/12/2014
Cleveland Clinic
mi
from
Cleveland, OH
Evaluating the Effect of ALLN-177 to Reduce Urinary Oxalate Excretion in Calcium Oxalate Kidney Stone Formers With Hyperoxaluria
A Phase 2 Multicenter, Open Label, Single Arm Study Evaluating the Effect of ALLN-177 to Reduce Urinary Oxalate Excretion in Recurrent Calcium Oxalate Kidney Stone Formers With Hyperoxaluria
Status: Enrolling
Updated: 11/12/2014
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Evaluating the Effect of ALLN-177 to Reduce Urinary Oxalate Excretion in Calcium Oxalate Kidney Stone Formers With Hyperoxaluria
A Phase 2 Multicenter, Open Label, Single Arm Study Evaluating the Effect of ALLN-177 to Reduce Urinary Oxalate Excretion in Recurrent Calcium Oxalate Kidney Stone Formers With Hyperoxaluria
Status: Enrolling
Updated:  11/12/2014
Omega Clinical Research
mi
from
Warwick, RI
Evaluating the Effect of ALLN-177 to Reduce Urinary Oxalate Excretion in Calcium Oxalate Kidney Stone Formers With Hyperoxaluria
A Phase 2 Multicenter, Open Label, Single Arm Study Evaluating the Effect of ALLN-177 to Reduce Urinary Oxalate Excretion in Recurrent Calcium Oxalate Kidney Stone Formers With Hyperoxaluria
Status: Enrolling
Updated: 11/12/2014
Omega Clinical Research
mi
from
Warwick, RI
Click here to add this to my saved trials